Virus associated adult t‐cell leukemia (ATL) in Japan: Clinical, histological and immunological studies

Virus associated adult T‐cell leukemia/lymphoma (ATLL), which includes both adult T‐cell leukemia (ATL) and its non‐leukemic counterpart (NLATL) was studied clinically, histologically, and immunologically. The disease usually occurred in the sixth decade in both sexes equally. The patients had a rapid clinical course with frequent leukemic changes, lymphadenopathy, hepatomegaly, and occasional skin rash. Bone marrow involvement with mild infiltration and hypercalcemia were more frequent in ATL than in NLATL. Histologically the disease was categorized as malignant lymphoma, diffuse pleomorphic type with cerebriform nuclear giant cells. The lymphoma was characterized by diffuse proliferation of tumor cells with irregular nuclear configurations, varying in size and shape, and the presence of giant cells with highly convoluted cerebriform nuclei. The giant cells seemed to be a diagnostic marker

[1]  H. Tsuda,et al.  Adult T‐cell leukemia cells expressing OKT 17 antigen in the activated state , 2007, Hematological oncology.

[2]  M. Yoshida.  Human leukemia virus associated with adult T-cell leukemia. , 1983, Gan.

[3]  H. Verspaget,et al.  ELISA assay for quantitative measurement of human immunoglobulins IgA, IgG, and IgM in nanograms. , 1983, Journal of immunological methods.

[4]  T. Waldmann,et al.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor , 1982, Nature.

[5]  E. Engleman,et al.  Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. , 1982, Journal of immunology.

[6]  M. Ichimaru,et al.  Final Results of Cooperative Study of VEPA [Vincristine, Cyclophosphamide (Endoxan), Prednisolone and Adriamycin] Therapy in Advanced Adult Non-Hodgkin's Lymphoma: Relation Between T- or B-Cell Phenotype and Response , 1982 .

[7]  M. Kikuchi,et al.  Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic study , 1982, International journal of cancer.

[8]  M. A. Everett,et al.  Identification of T-lymphocytes and T-subsets in human tonsil using monoclonal antibodies and the immunoperoxidase technic. , 1981, American Journal of Clinical Pathology.

[9]  M. Sasaki,et al.  ADULT T CELL LEUKEMIA HISTOLOGICAL CLASSIFICATION AND CHARACTERISTICS , 1979, Acta pathologica japonica.

[10]  T. Suchi,et al.  SOME PROBLEMS ON THE HISTOPATHOLOGICAL DIAGNOSIS OF NON‐HODGKIN'S MALIGNANT LYMPHOMA— A Proposal of a New Type— , 1979, Acta pathologica japonica.

[11]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.

[12]  T. Waldmann,et al.  The Sézary syndrome: a malignant proliferation of helper T cells. , 1976, The Journal of clinical investigation.

[13]  J. Yodoi,et al.  Letter: Two cases of T-cell chronic lymphocytic leukemia in Japan. , 1974, The New England journal of medicine.

[14]  H. Kronenberg,et al.  AN EVALUATION OF SERUM ERYTHROPOIETIN ESTIMATION BY A HEMAGGLUTINATION INHIBITION ASSAY IN THE DIFFERENTIAL DIAGNOSIS OF POLYCYTHEMIA , 1984, Pathology.

[15]  J. Yodoi,et al.  Adult T Cell Leukemia: Proposal as a New Disease and Cytogenetic, Phenotypic, and Functional Studies of Leukemic Cells , 1982 .

[16]  M. Kikuchi,et al.  Biopsy of Adult T Cell Leukemia , 1982 .

[17]  E. Sato.  Autopsy findings of adult T-cell lymphoma-leukemia , 1982 .

[18]  K. Lennert,et al.  MORPHOLOGY, CYTOCHEMISTRY, AND IMMUNOHISTOLOGY OF T CELL LYMPHOMAS , 1982 .

[19]  M. Kikuchi,et al.  Ultrastructure of adult T-cell leukemia/lymphoma , 1981, Virchows Archiv. B, Cell pathology including molecular pathology.

[20]  Y. Shimosato,et al.  Lymphoma and leukemia of t-lymphocytes. , 1981, Pathology annual.

[21]  H. Towler,et al.  Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .

[22]  National cancer institute sponsored study of classifications of non‐hodgkin's lymphomas. Summary and description of a working formulation for clinical usage , 2022 .